A 19F NMR study of the interaction of 3-fluoro-4-demethoxydaunomycin with the hexanucleotide d(TCCGGA)2  by Barr, Kathryn E. et al.
Volume 322, number 2, 173-176 FEBS 12422 
0 1993 Federation of European Biochemical Societies 00145793/93/%6.00 
May 1993 
A 19F NMR study of the interaction of 3-fluoro-4-demethoxydaunomycin 
with the hexanucleotide d(TCCGGA), 
Kathryn E. Barr”, Richard A. Russellb, Ronald N. Warrenerc and J. Grant Collins” 
aDepartment of Chemistry, University College, University of New South Wales, Australian Defence Force Academy, ACT 2600, 
Australia, bSchool of Chemistry, Deakin University, Geelong, Vie. 3217, Australia and ‘School of Chemistry, University College of 
Central Queensland, Rockhampton, Qld. 4702, Australia 
Received 22 March 1993 
19F NMR spectroscopy has been used to study the binding of the fluorinated anthracycline 3-fluoro-4-demethoxydaunomycin with the hexanucleo- 
tide d(TCCGGA)*. In the spectrum of the 1 : 1 anthracyclineed(TCCGGA), complex four resonances of approximately equal intensity were 
observed. This indicated that 4-demethoxydaunomycin intercalated at all possible sites with similar affinity. This suggests that the specific high 
affinity binding sites that are observed in anthracycline-DNA footprinting experiments are strongly regulated by the local DNA conformation. 
19F NMR; Anthracycline; Sequence specificity; Oligonucleotide; DNA 
1. INTRODUCTION 
While other modes of action have been suggested 
[l-3], it is generally believed that anthracyclines exert 
their anti-tumour activity mainly by interaction with 
DNA. Consequently, there has been considerable inter- 
est in establishing the preferred DNA binding site(s) of 
anthracycline drugs [4,5]. Recent studies aimed at estab- 
lishing the preferred DNA binding site(s) have provided 
conflicting results. Chaires et al. [4], using DNA foot- 
printing titration experiments, have reported that 
daunomycin exhibits a preference for 5’-CG (or GC) 
sites which are flanked on the 5’ side by an A.T base 
pair. Alternatively, Phillips and co-workers [5] have 
used DNA footprinting and transcription assays to pro- 
vide evidence that daunomycin prefers 5’-CA sites. 
We have previously demonstrated that by incorporat- 
ing a 19F label into the anthracycline molecule, the rela- 
tive binding affinity at specific two base sequences in an 
oligonucleotide can be determined by 19F NMR spec- 
troscopy [6]. In this initial study it was shown that 4- 
demethoxydaunomycin shows no significant preference 
for any particular binding site in the hexanucleotide 
d(CTGCAG),, which contains both 5’-GC and 5’-CA 
sites. This suggested that, contrary to the results of 
DNA footprinting and transcription experiments with 
the parent anthracyclines, 4-demethoxydaunomycin 
shows no over-riding binding preference for any partic- 
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In order to evaluate the general validity of our initial 
findings we have examined the binding of 3-fluoro-4- 
demethoxydaunomycin (3FD), shown in Fig. 1, with 
another synthetic hexanucleotide, d(TCCGGA),, that 
has a different base sequence to that used in the previ- 
ous study. This hexanucleotide not only contains differ- 
ent two and three base pair combinations, but also con- 
tains a run of pyrimidine bases and a run of purine 
bases, with only the central dinucleotide having the al- 
ternating pyrimidine-purine sequence that is generally 
considered to be favourable for anthracycline binding 
[4,51. 
2. EXPERIMENTAL 
2.1. Materials 
3-Fluoro-4-demethoxydaunomycin hydrochloride was prepared as 
previously described by Irvine et al. [7]. The hexanucleotide, 
d(TCCGGA), and Sephadex G-15 were purchased from Pharmacia 
P-L Biochemicals. D,O (99.96% D) was obtained from Sigma Chem- 
ical Co. All reagents used were of analytical grade. 
2.2. Preparation of the I : I 3FD-d(TCCGGA), complex 
To a 10 ml solution of d(TCCGGA), (1.73 pmol) in 10 mM phos- 
phate (pH 7) containing 100 mM NaCl and 1 mM EDTA was added 
a 3-fold excess of solid 3FD (which is insoluble in water) and the 
suspension was stirred overnight with occasional heating to 40°C. The 
suspension was then filtered and the filtrate freeze-dried to a red 
powder. A solution of this powder was made up in water and passed 
down a Sephadex G-15 column with water as the eluant. The 3FD- 
d(TCCGGA), complex eluted at the void volume. No other coloured 
fractions were eluted, although a very thin red band remained at the 
head of the Sephadex column. 
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Fig. 1. Structures of relevant anthracyclines: R, = F, R, = H, 
R, = CH,, 3-fluoro-4-demethoxydaunomycin (3FD); R, = H, 
R, = OCH,, R, = CH,OH, adriamycin. 
methyl resonance with the hexanucleotide’s thymidine methyl signal 
in the ‘H NMR spectrum. 
2.3. NMR spectroscopy 
All NMR spectra were recorded on a Varian XL-300 spectrometer 
operating at 282.2 MHz for the 19F nucleus. The spectra were accumu- 
lated with a 1.6 s recycle time and a 60” pulse. No proton decoupling 
could be carried out. 
3. RESULTS 
Fig. 2 shows the 19F NMR spectrum of the 1 : 1 3FD- 
d(TCCGGA), mixture. Since free 3FD is insoluble in 
water, these 19F signals must have arisen from fluori- 
nated anthracycline that is bound to the hexanucleotide, 
furthermore the presence of four peaks indicates that 
3FD exists in at least four unique environments. As only 
a 1 : 1 ratio of 3FD to d(TCCGGA), was obtained, 
although excess 3FD was initially added to the nucleo- 
tide solution (see section 2), and that 4-demethoxy- 
daunomycin has a high DNA binding constant 
(K = 106) [8], it is concluded that the binding stoichiom- 
etry is 1 : 1, with little or no 2 : 1 complex present in the 
mixture. Addition of excess 3FD directly to the 1 : 1 
complex in the NMR tube resulted only in a small in- 
crease in the area of peak A. This indicates that the 
hexanucleotide iscapable of binding a second 3FD mol- 
ecule, but in agreement with our previous study [6] no 
co-operativity in binding was observed. 
Studies on the interaction of anthracyclines with 
DNA have shown that these drugs bind to DNA by 
intercalation rather than associate in other ways [9,10]. 
Non-intercalative association with DNA has been pro- 
posed as a prelude to intercalation [l 11, however, these 
forms are thermodynamically and kinetically unfavour- 
able and would not be detected by NMR spectroscopy. 
In addition the results of Yen et al. [12] discount the 
possibility of the anthracycline sugar lying in the DNA 
major groove. Given these restraints it is concluded that 
the four resonances observed in Fig. 2 are due to the 
four unique intercalation isomers shown in Fig. 3. 
These conclusion are strongly supported by the results 
of our earlier study [6] of the binding of 3FD with the 
hexanucleotide d(CTGCAG),. In an analogous fashion, 
four 19F resonances were also observed and assigned to 
the four possible intercalation isomers; that is where the 
3FD bound between the S-CT-3’, S-TG-3’, 5’-GC-3’ 
and 5’-CA-3’ with the drug sugar moiety lying in the 
minor groove and pointed in the 3’ direction in each 
case. This proposal was further supported by a ‘H 
NMR study in which additional nucleotide proton reso- 
nances were observed upon addition of 3FD to the 
d(CTGCAG), solution that allowed identification of 
individual binding sites [13]. It was not possible to ob- 
tain similar ‘H NMR results for the 3FD- 
d(TCCGGA), complex, presumably due to the faster 
nucleotide dissociation rate of 3FD which results in 
only one exchange averaged resonance being observed 
for each nucleotide proton. 
While it was not possible to unambiguously assign 
each resonance in Fig. 2 to one of the intercalation 
isomers shown in Fig. 3, tentative assignments of peaks 
A and B were made. Previous work suggests that at low 
NaCl concentrations the broadest signal is due to the 
intercalation isomer where the sugar moiety is located 
between the penultimate and terminal base pairs [6], i.e. 
structure 4 in Fig. 3. At low NaCl concentrations the 
hexanucleotide is subject to maximum ‘fraying’ of the 
terminal base pairs, particularly the terminal base pair 
of the oligonucleotide that is not additionally stabilized 
by the stacking interaction of the anthracycline aro- 
matic ring system. This results in a relatively faster dis- 
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Fig. 2. 19F NMR spectrum of the 1 : 1 3FDd(TCCGGA), complex 
in D,O, 3 mM phosphate, pH 7, and 0 mM NaCl at YC. No fluorine- 
proton coupling is observed as the line-width of each resonance is 
significantly broadened due to 3FD exchange between binding sites. 
Above 35°C only one exchange averaged resonance is observed. 
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Fig. 3. A scheme showing the four intercalation isomers observed for 
the 1 : 1 3FD_d(TCCGGA), complex. The DNA duplex, idealized as 
a ladder, is shown with the minor groove facing out of the page. The 
intercalating, aromatic moiety of the 3FD molecule is shown as a 
heavy line parallel to the base pair ‘rungs’ of the ladder, while the 
aminoglycoside moiety is shown as a heavy line leading down the 
centre of the minor groove, terminated by a positive charge due to the 
amine cation. (nb. the intercalation site occupied in form 2 is not the 
same as that occupied in form 4. Relative to the DNA host, the entire 
drug molecule is rotated 180” going from 2 to 4, and hence can be 
considered to ‘perceive’ a different base sequence in each form.) 
sociation rate of the bound drug from this site, and 
hence the corresponding resonance shows the largest 
degree of exchange broadening. At higher NaCl concen- 
trations, where the duplex is significantly more stable, 
the results of the ‘H NMR study of 3FDd(CTGCAG), 
complex showed that the structure corresponding to 
isomer 1 in Fig. 3 exhibited the fastest 3FD dissociation 
rate [13]. This is consistent with other studies which 
have shown that the individual base pair melting tem- 
perature progressively increases in going from the ter- 
minal base pairs to the central residues of an oligonucle- 
otide [14,15]. Although intercalation of an anthracyc- 
line will increase the individual base pairs’ melting tem- 
peratures, the order of increasing thermal stability is 
preserved [141. 
In Fig. 2 it is observed that at 5°C and low salt 
concentration peak A is significantly wider than peaks 
B, C, and D, and becomes even broader at 18°C as 
shown in Fig. 4. It is also observed in Fig. 4 that as the 
NaCl concentration is increased peak A becomes rela- 
tively sharper. This indicates that the dissociation rate 
of the 3FD becomes relatively slower as the intercala- 
tion site becomes more stable. Alternatively, as the 
NaCl concentration increases peak B broadens (Fig. 4), 
suggesting that the intercalation site corresponding to 
peak B is progressively less stable with increasing NaCl 
concentration. In addition the resonances due to the 
intercalation isomers where the 3FD is bound towards 
the centre of the hexanucleotide (isomers 2 and 3) are 
the most kinetically stable with respect to temperature 
and salt concentration. From these considerations the 
four resonances observed in Fig. 2 are tentatively as- 
signed as follows; peak A to isomer 4, peak B to isomer 
1, while peaks C and D are assigned non-specifically to 
isomers 2 and 3. 
4. DISCUSSION 
The results from this study show that the 4- 
demethoxydaunomycin binds at all possible sites pres- 
ent in the hexanucleotide d(TCCGGA)2, including 
purine-purine and pyrimidine-pyrimidine sequences 
which have always been considered as lower affinity 
binding sites [4,5]. The 19F NMR results are a direct 
measure of the thermodynamic preference at each of the 
competing binding sites in this hexanucleotide. These 
results confirm the proposal of our previous study [6], 
and hence it is concluded that 4-demethyoxydaunomy- 
tin does not show a significant intrinsic preference for 
any particular two base sequence in its binding to an 
oligonucleotide. 
Although less well studied, recent evidence has been 
presented that 4-demethyoxydaunomycin, like the par- 
ent anthracyclines, does bind to DNA at a limited num- 
ber of high affinity sites [8]. This, coupled with the 
results presented here, indicates that factors other than 
the sequence at the specific intercalation site can signif- 
icantly regulate the relative anthracycline binding affin- 
ity to DNA. It has been known for some time that DNA 
is not homogeneous in structure but that along the pol- 
ymer strand there exists a heterogeneity of conforma- 
tion. This can significantly alter the DNA groove di- 
mensions thereby affecting the electrostatic and hydro- 
gen bonding interactions between the anthracycline and 
DNA. Furthermore, the degree to which the anthracy- 
cline planar aromatic system can overlap with the DNA 
bases would also be significantly affected. Therefore, it 
is suggested that the DNA binding specificity of anthra- 
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Fig. 4. 19F NMR spectrum of the 1 : 1 3FD-d(TCCGGA), complex 
in D,O, 10 mM phosphate, pH 7, over a range of NaCl concentrations 
(given to the right of each spectrum) at 18’C. 
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cyclines is significantly controlled by long-range struc- 
tural effects, in addition to specific hydrogen bonds at 
the intercalation site. 
While 4-demethoxydaunomycin has a slightly higher 
anti-tumour activity than daunomycin [8], it has been 
shown that the long axis of the bound anthracycline is 
oriented differently in the intercalation pocket com- 
pared to the parent anthracyclines [8,16]. This may re- 
sult in different binding preferences being observed for 
4-demethyoxydaunomycin; i deed, based on the tenta- 
tive assignments, the 3FD showed a marginally higher 
preference for the 5’-GG-3’ sequence. Consequently, the 
conclusions drawn from this study may only reflect the 
case for 4-demethoxydaunomycin, however, the results 
presented here support the recent study of Fox and 
Alam [17] who demonstrated that the DNA binding 
preference of the anthracycline nogalamycin is affected 
by local DNA dynamic and structural effects, i.e. by 
relatively long-range effects. 
DNA footprinting experiments have shown that an- 
thracyclines are capable of binding at a variety of differ- 
ent DNA sites, with a range of binding affinities 
[4,5,17]. It is the determination of the highest affinity 
sites that has produced conflicting results. In addition, 
in these footprinting studies it is generally observed that 
the anthracycline does not bind significantly at all pro- 
posed high affinity sequences. It would therefore appear 
reasonable to expect that local conformational differ- 
ences in DNA would strongly influence the anthracy- 
cline-DNA binding affinity at any particular sequence. 
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